MA28363A1 - Antagonistes des recepteurs muscariniques de l'acetylcholine - Google Patents

Antagonistes des recepteurs muscariniques de l'acetylcholine

Info

Publication number
MA28363A1
MA28363A1 MA29273A MA29273A MA28363A1 MA 28363 A1 MA28363 A1 MA 28363A1 MA 29273 A MA29273 A MA 29273A MA 29273 A MA29273 A MA 29273A MA 28363 A1 MA28363 A1 MA 28363A1
Authority
MA
Morocco
Prior art keywords
antagonists
acetylcholine receptors
muscarinic acetylcholine
muscarinic
receptors
Prior art date
Application number
MA29273A
Other languages
English (en)
Inventor
Dramane I Laine
Michael R Palovich
Alexander G Preston
Anthony William James Cooper
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA28363A1 publication Critical patent/MA28363A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA29273A 2004-01-13 2006-08-15 Antagonistes des recepteurs muscariniques de l'acetylcholine MA28363A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53609204P 2004-01-13 2004-01-13

Publications (1)

Publication Number Publication Date
MA28363A1 true MA28363A1 (fr) 2006-12-01

Family

ID=34794385

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29273A MA28363A1 (fr) 2004-01-13 2006-08-15 Antagonistes des recepteurs muscariniques de l'acetylcholine

Country Status (16)

Country Link
US (1) US20080249127A1 (fr)
EP (1) EP1711183A4 (fr)
JP (1) JP2007518740A (fr)
KR (1) KR20060129017A (fr)
CN (1) CN1929844A (fr)
AR (1) AR049464A1 (fr)
AU (1) AU2005204935A1 (fr)
BR (1) BRPI0506777A (fr)
CA (1) CA2552880A1 (fr)
IL (1) IL176775A0 (fr)
MA (1) MA28363A1 (fr)
NO (1) NO20063636L (fr)
PE (1) PE20050898A1 (fr)
RU (1) RU2006129289A (fr)
TW (1) TW200534855A (fr)
WO (1) WO2005067537A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007528420A (ja) * 2004-03-11 2007-10-11 グラクソ　グループ　リミテッド 新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
UY28871A1 (es) 2004-04-27 2005-11-30 Glaxo Group Ltd Antagonistas del receptor de acetilcolina muscarinico
JP2007537261A (ja) * 2004-05-13 2007-12-20 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
JP2008505118A (ja) * 2004-06-30 2008-02-21 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
WO2006055553A2 (fr) * 2004-11-15 2006-05-26 Glaxo Group Limited Nouveaux antagonistes des recepteurs muscariniques de type m3 de l'acetylcholine
JP2008537931A (ja) 2005-03-10 2008-10-02 セラヴァンス， インコーポレーテッド ムスカリン性レセプターアンタゴニストとして有用なビフェニル化合物
WO2007007282A2 (fr) * 2005-07-11 2007-01-18 Ranbaxy Laboratories Limited Antagonistes des recepteurs muscariniques
CL2009000248A1 (es) 2008-02-06 2009-09-11 Glaxo Group Ltd Compuestos derivados de pirazolo [3,4-b] piridin-5-il, inhibidores de la fosfodiesterasa de tipo iv (pde4) y antagonista de receptores muscarinicos de acetilcolina (machr); composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles en el tratamiento de enferemedades respiratorias y alergicas
UY31637A1 (es) 2008-02-06 2009-08-03 Farmacoforos duales-antagonistas muscarinicos de pde4
PE20091563A1 (es) 2008-02-06 2009-11-05 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
WO2010094643A1 (fr) 2009-02-17 2010-08-26 Glaxo Group Limited Dérivés de quinoline et applications associées dans la rhinite et l'urticaire
NZ595810A (en) * 2009-04-30 2013-05-31 Teijin Pharma Ltd Quaternary ammonium salt compound
WO2014023325A1 (fr) * 2012-08-06 2014-02-13 Fondazione Istituto Italiano Di Tecnologia Inhibiteurs de faah et de cox multicibles et leurs utilisations thérapeutiques
KR101538846B1 (ko) * 2013-07-30 2015-07-22 동아에스티 주식회사 신규한 바이페닐 유도체 및 그의 제조방법
BR112019003949B1 (pt) 2016-08-26 2023-12-12 Dong-A St Co., Ltd Sal de (r)-(1-metilpirrolidina-3-il)metil(3-cloro-4- fluoro-[1,1-bifenil] -2-il)carbamato inovador e uma forma cristalina dos mesmos
KR102239776B1 (ko) * 2016-08-26 2021-04-13 동아에스티 주식회사 (r)-(1-메틸피롤리딘-3-일)메틸(3'-클로로-4'-플루오로-[1,1'-비페닐]-2-일)카바메이트의 신규염 및 이의 결정형
EP3710483A4 (fr) 2017-11-16 2021-10-20 XL-protein GmbH Protéines de fusion vegfr/pdgfr pasylées et leur utilisation en thérapie
EP3720852A1 (fr) * 2017-12-04 2020-10-14 Friedrich-Alexander-Universität Erlangen-Nürnberg Ligands des récepteurs muscariniques à substitution fluorophényle ayant une sélectivité pour m3 sur m2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1140998B (it) * 1980-06-18 1986-10-10 Valeas Ind Chimica E Farmaceut Sali di endo-8-metil-8-sin-alchil-8-azoniabiciclo aperta par. quadrata 3.2.1. chiusa par. quadrata-ottan-3-alchilcarbossilati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo
CA2182568A1 (fr) * 1994-02-10 1995-08-17 Makoto Takeuchi Nouveau derive du carbamate et composition correspondante
WO2002004402A1 (fr) * 2000-07-11 2002-01-17 Banyu Pharmaceutical Co., Ltd. Derives d'ester
US7365167B2 (en) * 2001-11-26 2008-04-29 Cell Matrix, Inc. Humanized collagen antibodies and related methods
DE60310548T2 (de) * 2002-05-07 2007-05-10 Neurosearch A/S Diazabicyclische biarylderivate
US7041674B2 (en) * 2002-11-26 2006-05-09 Boehringer Ingelhiem Pharma Gmbh & Co. Kg Carbamic acid esters with anticholinergic activity
DE10255040A1 (de) * 2002-11-26 2004-06-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Carbaminsäureester mit anticholinerger Wirksamkeit
EP1613307A4 (fr) * 2003-04-07 2008-03-12 Glaxo Group Ltd Antagonistes du recepteur muscarinique m sb 3 /sb de l'acetylcholine

Also Published As

Publication number Publication date
CA2552880A1 (fr) 2005-07-28
EP1711183A2 (fr) 2006-10-18
EP1711183A4 (fr) 2009-04-01
WO2005067537A2 (fr) 2005-07-28
PE20050898A1 (es) 2005-11-06
AU2005204935A1 (en) 2005-07-28
WO2005067537A3 (fr) 2006-05-18
TW200534855A (en) 2005-11-01
NO20063636L (no) 2006-10-04
AR049464A1 (es) 2006-08-09
BRPI0506777A (pt) 2007-05-22
CN1929844A (zh) 2007-03-14
US20080249127A1 (en) 2008-10-09
JP2007518740A (ja) 2007-07-12
KR20060129017A (ko) 2006-12-14
IL176775A0 (en) 2006-10-31
RU2006129289A (ru) 2008-02-20

Similar Documents

Publication Publication Date Title
MA28631B1 (fr) Antagonistes des recepteurs muscariniques de l&#39;acetylcholine
MA28363A1 (fr) Antagonistes des recepteurs muscariniques de l&#39;acetylcholine
IS8522A (is) Ný M3 múskarínasetýlkólínviðtakamótlyf
IS8515A (is) Ný M3 múskarínasetýlkólínviðtakamótlyf
IL188112A0 (en) Muscarinic acetylcholine receptor antagonists
DK1682142T3 (da) M3-muscarin-acetylcholin-receptor-antagonister
IL172911A0 (en) Muscarinic acetylcholine receptor antagonists
EP1747219A4 (fr) Domaine de l&#39;invention antagonistes récepteurs d&#39;acétyle choline muscarinique
IL172912A0 (en) Muscarinic acetylcholine receptor antagonists
EP1725236A4 (fr) Nouveaux antagonistes du recepteur de l&#39;acetylcholine muscarinique m3
EP1749012A4 (fr) Antagonistes du recepteur d&#39;acetylcholine muscarinique
EP1824483A4 (fr) Antagonistes des recepteurs de l&#39;acetylcholine muscarinique
ZA200602783B (en) Muscarinic acetylcholine receptor antagonists
EP1937068A4 (fr) Antagonistes de recepteurs d&#39;acetylcholine muscarinique
EP1725238A4 (fr) Antagonistes du recepteur muscarinique a l&#39;acetylcholine m 3
EP1957075A4 (fr) Nouveaux antagonistes des recepteurs muscariniques de type m3 de l&#39;acetylcholine
EP1725240A4 (fr) Antagonistes du recepteur d&#39;acetylcholine muscarinique
EP1827439A4 (fr) Nouveaux antagonistes du recepteur d&#39;acetylcholine muscarinique m3
EP1765339A4 (fr) Antagonistes du recepteur muscarinique d&#39;acetylcholine
EP1781104A4 (fr) Antagonistes du recepteur d&#39;acetylcholine muscarinique
EP1648460A4 (fr) Antagonistes du recepteur de l&#39;acetylcholine muscarinique
EP1781103A4 (fr) Antagonistes du recepteur d&#39;acetylcholine muscarinique
MA28602B1 (fr) Pyridin-4-yl-ethynyl-imidazoles et pyrazoles en tant qu&#39;antagonistes des recepteurs mglur5
EP1751089A4 (fr) Nouveaux antagonistes du recepteur d&#39;acetylcholine muscarinique m3
AP2008004537A0 (en) Muscarinic receptor antagonists